Clinical Trials Logo

Clinical Trial Summary

Randomised, double-blind clinical trial to test humoral and cellular immunogenicity, and potential in-direct beneficial effect of the MMRvaxpro-vaccine administered at 6 months of age


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03780179
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase Phase 4
Start date April 15, 2019
Completion date January 7, 2022